文献速递头颈外科咽喉与嗓音

Ⅰ-Ⅱ期声门上型喉癌颈清扫应用中的治疗不一致性

Treatment discordance in the utilization of neck dissection for stage I-II supraglottic tumors.
PubMed 文献 · Head Neck · 2024-03-14

基于美国国家癌症数据库2004—2020年数据,纳入2080例cT1-2、N0、M0声门上型喉鳞状细胞癌保喉手术患者,633例(30.4%)行颈清扫;2018—2020年颈清扫率为39.0%(114/292)。多因素调整后,学术机构类型、术前活检及更根治性手术是接受颈清扫的显著预测因素。作者认为指南一致的颈清扫应用率仍低。

要点

  • 2080例cT1-2、N0、M0声门上型喉鳞状细胞癌保喉手术患者中,633例(30.4%)行颈清扫。
  • 2018—2020年颈清扫率为39.0%(114/292)。
  • 多因素调整后学术机构类型、术前活检、更根治性手术是颈清扫的显著预测因素。

核心结论

  • 这项全国性分析结果提示,Ⅰ-Ⅱ期声门上型喉鳞状细胞癌治疗中指南一致的颈清扫应用率仍低,作者强调需促进该人群颈清扫的实践。

研究设计与样本

  • 基于美国国家癌症数据库(2004—2020年)评价cT1-2、N0、M0声门上型喉鳞状细胞癌保喉手术中颈清扫使用趋势及相关因素,采用多因素调整Logistic回归,共2080例符合纳入标准。

主要发现

  • 2080例符合研究纳入标准患者中633例(30.4%)行颈清扫;2018—2020年颈清扫率为39.0%(114/292)。
  • 多因素调整后,学术机构类型、术前接受活检、更根治性手术是接受颈清扫的显著预测因素。

临床怎么用

  • 作者认为指南一致的颈清扫在Ⅰ-Ⅱ期声门上型喉鳞状细胞癌中的应用率仍低,并强调需促进该患者人群的颈清扫实践。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2018, the National Comprehensive Cancer Network treatment guidelines began recommending the use of neck dissection during surgical management of stage I-II supraglottic laryngeal squamous cell carcinoma (LSCC). METHODS: Trends and factors associated with the use of neck dissection during larynx-preserving surgery for patients with cT1-2, N0, M0 supraglottic LSCC in the National Cancer Database (2004-2020) were evaluated using multivariable-adjusted logistic regression. RESULTS: Of the 2080 patients who satisfied study eligibility criteria, 633 (30.4%) underwent neck dissection. Between 2018 and 2020, the rate of neck dissection was 39.0% (114/292). After multivariable adjustment, academic facility type, undergoing biopsy prior to surgery, and more radical surgery were significant predictors of receiving neck dissection. CONCLUSIONS: The results of this national analysis suggest that the utilization of guideline-concordant neck dissection for management of stage I-II supraglottic LSCC remains low and highlight the need to promote the practice of neck dissection for this patient population.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Gilja S, Vasan V, Kumar A, et al. Treatment discordance in the utilization of neck dissection for stage I-II supraglottic tumors. Head Neck. 2024. PMID: 38482913. doi:10.1002/hed.27736

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。